세계 인공 추간판 시장 규모는 2023년 15억 9,000만 달러, 2030년까지 30억 1,000만 달러에 달할 것으로 예상되며, 2024-2030년의 예측 기간 동안 연평균 11.16% 성장할 것으로 예상됩니다. 시장은 노인 인구 증가, 추간판 퇴행성 질환의 유병률 증가, 외상 사례 및 스포츠 부상 증가, 특히 제품 개발 활동 증가와 같은 요인으로 인해 긍정적인 성장을 보일 것으로 예상됩니다.
인공 추간판 시장 역학
인공 추간판 시장의 주요 촉진요인 중 하나는 전 세계적으로 노인 인구가 증가하고 있다는 것입니다. 의료 시설의 개선과 가처분 소득 증가는 삶의 질과 전반적인 평균 수명을 향상시키는 주요 요인이었습니다. 노년층은 척추 퇴행성 질환 등 많은 질병과 장애에 취약한 인구의 대부분을 차지합니다. 예를 들어, 유엔의 World Population Ageing 보고서에 따르면 2020년 전 세계 65세 이상 인구는 약 7억 2,700만 명에 달할 전망입니다. 또한, 향후 30년간 노인 인구는 15억 명 이상으로 두 배 이상 증가할 것으로 예측됩니다. 고령층은 척추 측만증, 추간판 퇴행성 질환, 골다공증 및 기타 유사한 질환과 같은 뼈 관련 질환의 위험이 높기 때문입니다. 따라서 2024-2030년의 예측 기간 동안 인공 추간판 치환술에 대한 수요가 증가할 것으로 예상되며, 이는 세계 시장 성장을 가속하는 요인으로 작용할 것으로 보입니다.
2018년 Global Spine Journal에 발표된 Ravindra 등의 'Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide'에 따르면, 매년 약 2억 6,000만 명이 퇴행성 척추질환으로 고통받고 있습니다. 600만 명이 퇴행성 척추 질환과 요통으로 고통받고 있습니다. 이 데이터에 따르면 2018년 기준 매년 4억 3천만 명이 증상성 추간판 변성증, 1억 3천만 명이 척추관 협착증, 3,900만 명이 척추 전방전위증을 앓고 있다고 합니다.
또한, 요통은 척추 관련 장애를 나타내는 주요 징후 중 하나로 여겨지고 있으며, Journal of Hospital Management and Health Policy에 발표된 Mattiuzzi 등의 'Current Epidemiology of Low Back Pain'에 따르면, 2020년 요통은 연간 2억 4,590만 건, 유병률과 장애 조정 생존기간은 각각 2억 4,500만 건, 1억 2,000만 건으로 세계 15위를 기록할 것으로 예상됩니다. Back Pain'에 따르면 2020년 요통의 발병 건수, 유병자 수, 장애 조정 생존년수(DALYs)는 각각 연간 2억 4,590만 건(세계 15위), 5억 7,700만 건(세계 15위), 6,490만 DALYs(세계 6위)에 달할 전망입니다. 이 논문은 또한 요통의 위험은 남성에 비해 여성이 약간 더 높다고 밝혔습니다. 만성 요통은 심각한 척추 질환이 기저에 있을 수 있다는 가장 흔한 징후 중 하나입니다.
위의 환자 생활에 대한 정보는 퇴행성 척추 질환이 얼마나 큰 영향을 미치는지 보여줍니다. 이러한 적응증은 쇠약감, 하지 통증, 요통 등 다양한 임상 증상을 동반하여 삶의 질을 크게 떨어뜨립니다.
외과적으로, 추간판 퇴행성 질환은 두 가지 다른 접근법으로 치료합니다. 척추 고정술은 두 개의 척추뼈를 고정하기 때문에 척추의 움직임이 제한되어 척추의 경직과 운동성 저하를 유발할 수 있습니다. 따라서 척추 고정술의 단점을 보완하기 위해 인공 추간판 치환술과 같은 척추 비고정 접근법이 최종 사용자들에게 인기를 끌고 있습니다.
따라서 전 세계 시장에서 척추 인공 디스크에 대한 수요가 증가하고 있습니다. 이 장치는 기능적인 척추 단위의 이동성을 유지하면서 안정화를 제공하고 통증을 제거하도록 설계되어 인기를 끌고 있습니다. 인공 추간판은 척추의 자연 구조를 유지하면서 적응증을 치료합니다. 또한 인공 추간판은 자연 추간판 역할을 하여 인접한 추간판으로부터 압력을 제거하여 주변 압력을 완화하여 인접한 추간판의 손상을 줄이는 데도 도움이 됩니다.
그러나 골변성이 진행된 환자들에게만 적용될 수 있는 제한적인 적용 가능성과 시판 허가를 위한 까다로운 규제 절차는 인공 추간판 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.
이 보고서는 세계 인공추간판 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등을 전해드립니다.
Aritificial Disc Market By Product Type (Cervical And Lumbar), By Material (Metal-On-Polymer, and Others), By End User (Hospitals and Specialty Clinics), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising geriatric population and increasing prevalence of degenerative spine disorders.
Global Artificial Disc Market was valued at USD 1.59 billion in 2023, growing at a CAGR of 11.16% during the forecast period from 2024 to 2030 to reach USD 3.01 billion by 2030. The artificial disc market is slated towards a positive market growth owing to factors such as increasing geriatric population, rising prevalence of degenerative disc disorders, growing number of trauma cases & sports-related injuries, and increasing product development activities among other factors.
Aritificial Disc Market Dynamics:
One of the main drivers of the artificial disc market is the growing geriatric population around the world. Improvements in health facilities and disposable income were key factors in improving quality of life and overall life expectancy. The elderly constitute a large part of the subpopulation susceptible to many diseases and disorders such as degenerative diseases of the spine. For instance, according to the United Nations, World Population Ageing report, in 2020, there were around 727 million people over the age of 65 worldwide. It was also noted that the number of older people is expected to double to more than 1.5 billion in the next three decades. Since the elderly population has a higher risk of bone-related diseases, such as scoliosis, degenerative disc disease, osteoporosis, and other similar diseases. So the demand for artificial disc replacement will increase during the forecast period 2024-2030 which will drive the market growth globally.
As per the research published in the Global Spine Journal, titled "Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide" by Ravindra et al published in 2018, approximately 266 million individuals suffered from degenerative spinal disease and lower back pain each year. The data further mentioned that in 2018, 403 million presented with symptomatic disc degeneration, 103 million with spinal stenosis, and 39 million with spondylolisthesis annually.
Furthermore, lower back pain is considered as one of the chief complaints pointing towards underlying spine-related disorder. According to the research published in the Journal of Hospital Management and Health Policy, titled "Current Epidemiology of Low Back Pain" by Mattiuzzi et al, in 2020, incidence, prevalence and disability-adjusted life years (DALYs) of LBPs are 245.9 million cases per year (15th worldwide cause), 577.0 million cases (15th worldwide cause) and 64.9 million DALYs (6th worldwide cause), respectively. The paper further stated that the risk of LBP is marginally higher in women compared to men. Chronic lower back pain is one of the commonest complaint that may point towards an underlying serious spinal disorder.
The above-stated facts indicate the significant impact the degenerative spine disorders can have on patients' lives. These indications are associated with a diverse range of clinical symptoms such as weakness, low extremity pain, back pain and can result in the significant reduction in the quality of life.
Surgically, degenerative disc disease is treated by two different approaches- spinal fusion approach results in the fusion of two vertebrae together, thereby limiting the motion of the spine and may cause stiffness and decreased motion of the spine. Therefore, to address the shortcomings associated with the spinal fusion procedures, spinal non fusion approaches such as artificial discs replacement are gaining popularity among end users.
Therefore, there has been a growing demand for spinal artificial discs in the market globally. These devices are gaining popularity as they are designed with the intent to provide stabilization and eliminate pain while preserving motion of the functional spinal unit. Artificial discs treat the indication while maintaining the natural structural of the spine. Moreover, they also help in reducing the damage to adjacent discs as the artificial discs function as the natural disc and take off the pressure from the adjacent discs thereby relieving the pressure from surrounding areas.
However, limited applicability in patients with advanced bone degeneration and stringent regulatory process for market approval may be certain impeding factors to the artificial disc market growth.
Artificial Disc Market Segment Analysis:
Artificial Disc Market by Product Type (Cervical and Lumbar), by Material (Metal-On-Polymer, and Others), by End User (Hospitals and Specialty Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the artificial discs market, the lumbar artificial discs are expected to account for the faster growth in the artificial disc market during the forecast period. This could be attributed to the higher prevalence of lumbar disc degeneration compared to cervical disc degeneration. This can be attributed to a range of factors such as degenerative disc disease, rising prevalence of obesity among others. As per the factsheet provided by the WHO on obesity (2023), in 2016, over 1.9 billion adults in the age group of 18 years and older were overweight and over 650 million were obese. Being overweight impacts the structural integrity of the spine and puts more load on the vertebrae which may lead to back pain which may result in the deterioration of intervertebral discs in the lumbar region over time. As the area of spine commonly affected is the lumbar part, the factors mentioned above may drive the demand for artificial lumbar discs in the forecast period.
Along with that, increasing product-related safety studies in order to establish the efficacy of artificial lumbar discs offer a way to increase product reliability among end users. For instance, in July 2022, Aesculap Implant Systems, LLC announced the long-term reporting from its pivotal trial for the activl® artificial disc. The long-term evidence (7-year study period) from the US Food and Drug Administration- non-inferiority study presented in this paper supports lumbar total disc replacement as a safe and effective treatment option for degenerative disc disorder. Such studies provide evidence ensuring long-term product safety thereby promoting their uptake in the market.
North America is expected to dominate the overall Artificial Disc Market:
Among all the regions, North America is expected to account for the largest share in the artificial disc market. Owing to significant growth factors such as rising prevalence of geriatric population, increasing incidence of spinal disorders, and rising government initiatives are expected to aid in the growth of the North America Artificial Disc Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness regarding the progression of spinal diseases and possible treatments also propelled the market growth in this region.
As per the data provided by the United States Bone and Joint Initiative (2023), musculoskeletal diseases affect more than one out of every two persons in the United States in the age group of 18 year and above, and affects nearly three out of four people in the age group of 65 and above. The three commonest musculoskeletal conditions which resulted in health care visits to physicians' offices, emergency departments, and hospitals occur each year are arthritis, back pain, and trauma. As per the data provided by the Centers for Disease Control and Prevention, in 2019, about 40 million US workers reported the problem of low back pain. Low back pain is one of the chief complaints that indicate towards the underlying disc degeneration and may result in the replacement of spinal discs which may boost the artificial disc market growth in the country as well as the region.
Moreover, the presence of a well-regulated reimbursement channel for spine surgeries and the presence of highly equipped healthcare facilities in the United States are further expected to drive the North America Artificial Disc market during the forecast period from 2024-2030.
Furthermore, in February 2022, NuVasive Inc. acquired Simplify Medical helping the former expand their product portfolio with the acquisition of the most clinically effective cTDR technology and further distinguishes NuVasive's cervical portfolio in the market.
Therefore, considering the parameters mentioned above coupled with factors such as mergers and acquisitions of the companies operating in the artificial disc manufacturing domain in the country, the market for artificial discs looks promising in the United States which will drive the overall North America market growth during the forecast period from 2024-2030.
Artificial Disc Market Key Players:
Some of the key market players operating in the artificial disc market includes Stryker, Zimmer Biomet, DePuy Synthes (Medical Devices Business Services, Inc.), Medtronic, Globus Medical, B. Braun Melsungen AG, Orthofix Medical Inc., NuVasive Inc., Centinel Spine®, LLC, SYNERGY SPINE SOLUTIONS INC., AxioMed LLC, Spineart, NEURO FRANCE Implants, Norm Medical Devices Co. Ltd., Ackermann Medical GmbH & Co. KG, Aditus Medical, Evospine GmbH, Prodorth Spine, SIGNUS Medizintechnik GmbH, Spine Innovations SAS, and others.
Recent Developmental Activities in Artificial Disc Market:
In April 2022, NuVasive Inc. received the product approval from the US FDA for the Simplify® Cervical Artificial Disc for two-level cervical total disc replacement (cTDR).
In March 2018, Orthofix International N.V acquired Spinal Kinetics LLC which helped Orthofix expand their Spine Fixation product portfolio with the inclusion of the Spinal Kinetics M6(TM) artificial discs.
Key Takeaways from the Artificial Disc Market Report Study
Market size analysis for current artificial disc market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the artificial disc market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the global artificial disc market.
Various opportunities available for the other competitor in the artificial disc market space.
What are the top performing segments in 2023? How these segments will perform in 2030?
Which is the top-performing regions and countries in the current artificial disc market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for artificial disc market growth in the coming future?
Target Audience who can be benefited from this Artificial Disc Market Report Study
Artificial Disc products providers
Research organizations and consulting companies
Artificial Disc-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in artificial disc
Various End-users who want to know more about the artificial disc market and latest technological developments in the artificial disc market.
Frequently Asked Questions for Artificial Disc Market:
An artificial disc is a prosthetic device which is used in the replacement of diseased vertebrae and substitute for the functionality of normal disc in providing load bearing capacity and allow for unhindered and painless movement of the spine.
Global Artificial Disc Market was valued at USD 1.59 billion in 2023, growing at a CAGR of 11.16% during the forecast period from 2024 to 2030 to reach USD 3.01 billion by 2030.
The artificial disc market is slated towards a positive market growth due to factors such as increasing geriatric population, rising prevalence of degenerative disc disorders, growing number of trauma cases and sports-related injuries, and increasing product development activities among other factors.
Some of the key market players operating in the artificial disc market includes Stryker, Zimmer Biomet, DePuy Synthes (Medical Devices Business Services, Inc.), Medtronic, Globus Medical, B. Braun Melsungen AG, Orthofix Medical Inc., NuVasive Inc, Centinel Spine®, LLC, SYNERGY SPINE SOLUTIONS INC, AxioMed LLC, Spineart, NEURO FRANCE Implants, Norm Medical Devices Co. Ltd., Ackermann Medical GmbH & Co. KG, Aditus Medical, Evospine GmbH, Prodorth Spine, SIGNUS Medizintechnik GmbH, Spine Innovations SAS, and others.
North America is expected to hold the highest share in the revenue in the Artificial Disc market during the forecast period. This can be ascribed to the significant growth factors such as rising prevalence of geriatric population, increasing incidence of spinal disorders, rising government initiatives, and increased awareness regarding the disease progression and possible treatments are expected to aid in the growth of the North America Artificial Disc Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness regarding available treatments for spine-related disorders also propelled the market growth in this region.